Management Name : Mr PRASERT JIRAVANSTIT | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 15/07/2016

Management Name : Mr PRASERT JIRAVANSTIT | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 06/09/2017

Management Name : Mr WIBOON UTSAHAJIT | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 15/07/2016

Management Name : Mr WIBOON UTSAHAJIT | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 06/09/2017

Management Name : Mr WIBOON UTSAHAJIT | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 15/06/2018

Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 HEALTH

problems and developing the well-being of the community, society, public health or the environment, without pursuing the highest returns for shareholders. Since the rule would require that social enterprises

Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Company Q3 30/09/2022 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q3 30/09/2022 HEALTH

DATA PRIVACY HEALTH & WELL-BEING 25% OF TOTAL SALES VOLUME OF B2B AND B2C PRODUCTS AND SERVICES HELP PROMOTE HEALTH AND/OR WELL-BEING SOCIAL IMPACT 500,000 PERSONS JOBS SUPPORTED TO GENERATE INCOMES FOR

Derivative Warrants | ALIHEA41C2310A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2023